Kailash Chand Pandey
Name: Kailash C Pandey, Ph.D
Address:
National Institute of Malaria Research
Host-parasite interaction Biology Group
Protein-Protein interactions unit
Sector-8, Dwarka, New Delhi-110077
Lab. 011-25307219, Cell; 8826712145
Fax: 011-25307215
e-mail: [email protected]; http://www.researcherid.com/rid/H-5048-2011
EDUCATION
2002
Ph.D in Biotechnology, International Centre for Genetic Engineering and
Biotechnology, New Delhi, affiliated with Jamia Hamdard University, New Delhi,
INDIA
1996
M.Sc. in Biochemistry, Dr. Ram Manohar Lohia Avadh University, Faizabad, INDIA
1991
P.G Diploma in Biotechnology, Delhi University, New Delhi, INDIA
1990
B.Sc. (Honors) in Biochemistry, Delhi University, New Delhi, INDIA
Employment
2010-Present
Scientist (Ramalingaswami Fellow), National Institute of Malaria Research
2009-2010
Research Scholar (EMBO Project), University of Exeter, UK.
2006-2008
Associate Specialist III, University of California San Francisco,
School of Medicine, Division of Infectious Disease, USA.
2004-2006
Assistant Specialist II, University of California San Francisco,
School of Medicine, Division of Infectious Disease, USA.
2002-2004
Visiting Post-Doctoral Scholar, University of California San Francisco,
School of Medicine, Division of Infectious Disease, USA.
1996-1998
Research Assistant, International Centre for Genetic Engineering and
Biotechnology, New Delhi, INDIA.
1992-1994
Research Technician, National Institute of Immunology, New Delhi, INDIA.
Research Specialization: Protein Chemistry of Malaria Parasite
Page 1
Kailash Chand Pandey
Major Research Accomplishments


Recently awarded a Ramalingaswami fellowship for five year (2010-2015) by Department of
Biotechnology, India.
Engineering nucleotide specificity without changing binding site residues: the emerging role of
gatekeeper residues in drug discovery.

Discovered a new molecule named falstatin, an endogenous cysteine protease inhibitor in the
human malaria parasite, which facilitates erythrocyte invasion.

Discovered a hemoglobin binding domain in a major cysteine protease of human malaria
parasite, P. falciparum.

Major contribution to find out structural basis for unique mechanisms of folding and
hemoglobin binding by malarial cysteine protease as drug targets.

Discovered three independent domains for inhibition, refolding and activity of novel cysteine
proteases of human malaria parasite as drug targets.

Characterization of erythrocyte binding proteins of malaria parasite as recombinant malaria
vaccine candidates.

Developed a new technology in the field of protein folding. International patent for inventing
methods for renaturation of polypeptide.
Mentoring/ Teaching Experience
Mentoring Ph.D students and undergraduates in the field of Protein Chemistry at University of
Exeter, UK, 2009-2011.
Mentoring and teaching (Biochemistry) to San Francisco state high school students, and
mentoring graduate students from University of California Berkeley, USA, 2004-2007.
Mentoring post–doc fellows from University of California San Francisco in the field of protein
chemistry, USA, 2004-2007.
Supervising summer trainees in the field of protein chemistry at International Centre for Genetic
Engineering and Biotechnology, New Delhi, INDIA, 1996-2002.
Honored as a group leader at international meeting for host-pathogen interaction organized by
Tata Institute of Fundamental Research, Mumbai and green hill campus Mahabaleshwar, INDIA,
18-23 November, 2000,
Membership
Member of the Malaria Journal Club organized by University of California San Francisco, and
University of California Berkeley, 2005-2008, USA.
Member of Bay Area Malaria Meeting organized by University of California San Francisco,
University of California Berkeley and Stanford University, 2005-2008, USA.
Member of International Society of Protistologists and the British Society for Protist Biology,
2009-2011.
Coordinator of Ph.D Students seminar series at National Institute of Malaria Research, New Delhi
(2010-present)
Page 2
Kailash Chand Pandey
Fellowship
Ramalingaswami fellowship for five year (2010-2015) by Department of Biotechnology, India.
National eligibility fellowship for Lectureship/Assistant Professorship in Biochemistry by
Agriculture Scientist Recruitment Board, New Delhi, Govt. of India, 1998.
Award
Travelling grant by International Society of Protistologists for joint meeting of the international
society of Protistologists, University of KENT, Canterbury, 18-23 July, UK.
Patent
International Patent: Invention of a method for polypeptide renaturation (erythrocyte binding
protein of P.vivax and P.falciparum). European Patent Code: C07K14/445; and International
Patent Code: C07K14/195. Inventor: Chetan E Chitnis., Kailash C Pandey., Singh S., Yazdani
S., Pattnaik P., Date; 14 Feb. 2002.
Publications
Important publications (including paper in press, and communicated)
1. Srinivasan Sundararaj, Deepak Singh, Ajay Saxena, Puran Sijwali, Rajnikant Dixit, Kailash C.
Pandey* (2012). The Ionic and Hydrophobic Interactions Are Required for the Auto Activation of
Cysteine Proteases of Plasmodium falciparum PLoS One 7(10): e47227. doi:10.1371.
2. Kailash C. Pandey (2011) Cysteine Proteases of Human Malaria Parasites (Invited Review
Article/Centenary celebrations article, Journal of parasitic diseases, 35, 94-103.
3. Kailash C. Pandey, Rajnikant Dixit (2012) Structure-function of Falcipains; malarial cysteine
proteases. Invited review article, Journal of tropical Medicine, 345195: DOI: 10.1155/2012/345195.
4. Kailash C. Pandey, Robin Maytum, Karleigh A.Hamblin, Mark van der Giezan, Daron M. Standley.
Flipping the switch on the electrostatic gatekeeper in succinyl-CoA synthetase; Communicated, PNAS.
2013.
5. Kailash C. Pandey, David T. Barkan, Andrej Sali, and Philip J. Rosenthal. Regulatory elements
within the prodomain of falcipain-2, a cysteine Protease of the malaria parasite Plasmodium
falciparum; PLoS One 2009, 27; 4 (5) e 5694.
6. Pandey KC, Singh N, Kapur SA, Bogyo M, Rosenthal PJ. Falstatin, a Cysteine Protease Inhibitor of
Plasmodium falciparum, facilitates Erythrocyte Invasion. PLoS Pathogens. 2006; 2: e117.
7. Pandey KC, Wang SX, Sijwali PS, Lau AL, Mckerrow JH, Rosenthal PJ. The Plasmodium
falciparum cysteine protease falcipain-2 captures its substrate, hemoglobin, via a unique motif.
PNAS.2005; 102: 9138-9143.
8.
Wang SX, Pandey KC, Somoza JR, Brinen LS, Sijwali PS, Kortemme T, Rosenthal PJ, Mckerrow JH.
Structural basis for unique mechanisms of folding and hemoglobin binding by a malarial protease.
PNAS.2006;103:11503-11508.
Page 3
Kailash Chand Pandey
9. Wang SX, Pandey KC, Scharfstein J, Whisstock J, Huang RK, Jacobelli J, Fletterick RJ, Rosenthal
PJ et. al. The structure of chagasin in complex with a cysteine protease clarifies the binding mode and
evolution of an inhibitor family. Structure. 2007; 15; 535-543.
10. Pandey KC, Sijwali PS, Singh A, Na BK, Rosenthal PJ. Independent intramolecular
mediators of folding, activity, and inhibition for the Plasmodium falciparum cysteine protease
falcipain-2. J Biol Chem. 2004; 279:348-3491
11. Pandey KC, Singh S, Pattnaik P, Pillai CR, Pillai U, Lynn A, Jain SK, Chitnis CE. Bacterially
expressed and refolded receptor binding domain of Plasmodium falciparum EBA-175 elicits
invasion inhibitory antibodies. Mol Biochem Parasitol. 2002 ;123:23-33.
12.
Singh S, Pandey KC, Chattopadhayay R, Yazdani SS, Lynn A, Bharadwaj A, Ranjan A,
Chitnis CE. Biochemical, biophysical, and functional characterization of bacterially
expressed and refolded receptor binding domain of Plasmodium vivax duffy-binding protein.
J Biol Chem.2001, 6:17111-17116.
13. Dixit R, Rawat M, Kumar S, Pandey KC, Adak T, Sharma A. Salivary gland Transcriptome
analysis in response to sugar feeding in malaria vector Anopheles stephensi; J Insect Physiol. 2011
Jul 20.
14. Kerr ID, Lee JH, Farady CJ, Marion R, Rickert M, Sajid M, Pandey KC, Caffrey CR, Legac
J, Hansell E, McKerrow JH, Craik CS, Rosenthal PJ, Brinen LS. Vinyl sulfones as
antiparasitic JBC,2009, 38, 25697-703.
15. Kerr ID, Lee JH, Pandey KC, Harrision A, Sajid M, Rosenthal PJ, Brinen LS. Structure of
falcipain- 2 and falcipain-3 bound to small molecule inhibitors: Implications for substrate
specificity. J Med Chem. 2009; (3) 852-7.
16. Naresh Singh, Puran S.Sijwali, Kailash C Pandey and Philip J Rosenthal. Plasmodium
falciparum: Biochemical characterization of the cysteine protease falcipain-2’. Experimental
Parasitology,2006; (3); 181-92.
17. Na BK, Shenai BR, Sijwali PS, Choe Y, Pandey KC, Singh A, Craik CS, Rosenthal PJ.
Identification and biochemical characterization of vivapains, cysteine proteases of the
malaria parasite Plasmodium vivax. Biochem J. 2004 ;378:529-538.
18. Pandey AV, Bisht H, Babberwal VK, Srivastava J, Pandey KC, and Chauhan VS.
Mechanism of malarial haem detoxification inhibition by chloroquine. Biochem J.
2001;355:333-338.
19. Chitnis C., Chatopadhya R., Okoyeh,J.N., Pandey KC, Ranjan A. and Singh S., A super
family of Plasmodium proteins involved in erythrocyte invasion and cytoadherence:
implications for malaria vaccine development. The Immunologist 1998, Suppl 1, 193.
Invited Talks
Invited speaker at National Conference-Cum- Workshop on “Search for Antimalarial : Mechanism
Based Approach” organized by JNU and ICGEB, New Delhi, April, 27-30, 2012, India.
Invited speaker at XI Symposium on Vectors and Vector Borne Diseases, organized by ICMR,
India, Jabalpur, 15-17 Oct, 2011. 011
Invited speaker at International society of Protistologists and the British society for Protist
Biology, University of KENT, Canterbury, 18-23 July 2010.
Guest speaker at School of Biological and Chemical Sciences, Queen Mary University of
London, Mile End Road, London E1 4NS, UK, 2009
Page 4
Kailash Chand Pandey
Guest speaker at School of Biosciences, Centre for Eukaryotic Evolutionary Microbiology,
University of Exeter, Stocker Road, Exeter EX4 4QD, UK, 2009.
Invited speaker at Malaria Research Centre, Indian Council of Medical Research, 22 Sham
Nath Marg, Delhi-110054, India, 2008.
Bay area malaria meeting organized by University of California, San Francisco, University of
California, Berkeley and Stanford University, 2006.
Annual meeting organized by GlaxoSmithKline, and UCSF: Malarial Cysteine Proteases as Drug
Target: Olema Inn, Marine, CA, USA, 2006.
Annual meeting organized by GlaxoSmithKline and University of California San Francisco, Drug
Discovery in Malaria, Olema Inn, Marine, CA, USA, 2005.
Molecular Parasitology meeting XIII, Marine Biological Laboratory Woods Hole, MA, USA, 2003.
Presentations / workshop in International Conferences
Gordon Research Conferences for Proteolytic enzymes and their inhibitors, July 2006, New London, NH,
USA.
Molecular Parasitology Meeting from XIII to XVI, September 2003-2006 at Marine Biological
Laboratory Woods Hole, MA, USA.
Host-Pathogen Interaction Organized by Tata Institute of Fundamental Research, Mumbai and Green
Hill Campus Mahabaleshwar, 18-23 November, 2000, INDIA.
Workshop on High Performance Liquid Chromatography Organized by.Sigma-Aldrich, 7-9 April, 1999
Bangalore, INDIA
The 10th International Congress of Immunology. 1-7 November, 1998 at New Delhi, INDIA
2nd Global Meet on Parasitic Diseases. 18-22 August, 1997 at Hyderabad, INDIA
Book Chapter (In press); Cysteine Proteases of Human Malaria Parasites by Kailash C Pandey; Role of
proteases in cellular dysfunction” publishing by Springer.
Research Support (Ongoing Research Projects)
1. Proteases as a drug targets for malarial parasite, and structure-function analysis of falstatin as
a vaccine candidate for malaria.
Reference number of Project: BT/HRD/35/02/16/2009
Investigator: Dr. Kailash C Pandey
Status: Ongoing (2010-2015)
Total Cost: 70, 00,000 (Rs. 70 Lakh)
Name of the Funding Agency: DBT, India
2. Finding the “Gatekeeper residues’ and engineering “substrate specificity” by changing the
charm of Sucinyl CoA Synthetase of malaria parasite as drug target.
Reference number of Project: NIMR/PB/2011/146
Page 5
Kailash Chand Pandey
Status: Ongoing (2011-2013)
Total Cost: 16,00,000 (Rs. 16 Lakh)
Name of the Funding Agency: ICMR, India
3. Characterization of Metacaspase-2 (MCA-2) as a New Potential Drug Target of P.falciparum
and P.vivax; A Mechanism Based Approach for Anti-Malarial Chemotherapy. (Concept of
proposal is already approved by Indian Council of Medical Research, India, under Extramural
Programme of ICMR). Ref. No. of Project; 2012-1655. Tentative budget; 75 Lakhs
Malarial cysteine proteases inhibitor based on hot-spot; Biochemical based approach. (
(Concept of proposal is already approved by SAC of NIMR, and approved for extramural
grant from CSIR. Tentative budget;45 lakhs.
4.
Mentors;

Dr. Chetan Chitnis, ICGEB, New Delhi ( Ph.D Mentor)

Prof. Philip J. Rosenthal, UCSF, USA (Post–Doc Mentor)

Dr. Mark van der Giezen, University of Exeter, UK (Post–Doc Mentor)

Dr. Neena Valecha, NIMR, New Delhi (Host Institute Mentor)
Page 6